Switch View
© PR Newswire
06.11.2025
ISIN: US09062W2044
BioLife Solutions Inc
BLFS
LISTED
NASDAQ
BioLife Solutions Reports Third Quarter 2025 Financial Results
News Preview
Cell Processing revenue of
$25.4 million, up 33% over Q3 2024
GAAP gross margin of
62%
and non-GAAP adjusted gross margin of
64%
GAAP...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US26622P1075
Doximity Inc
DOCS
LISTED
NYSE
Doximity Announces Fiscal 2026 Second Quarter Financial Results
News Preview
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025.
“Our platform continues to grow with new AI tools to save physicians’ time,” said Jeff Tangney, co-founder and CEO of Doximity. “In Q2, a record 650,000 prescribers used our...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed Reports Q3 2025 Financial Results and Business Updates
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported financial results for the third quarter ended September 30, 2025 and provided business updates.
“2025 continues to be a year of strong execut...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
06.11.2025
ISIN: US1570851014
Cerus Corp
CERS
LISTED
NASDAQ
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
News Preview
Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update.
“We continue to make great strides in improving the safety and availability of transfused blood components around the globe and the record quarterly product revenue results reflect that progress. Produ...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
06.11.2025
ISIN: US53566P1093
Lineage Cell Therapeutics Inc.
LCTX
LISTED
TLV
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today reported its third quarter 2025 financial and operating results and will host a conference call today at 4:30 p.m. Eastern Time to discuss these...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US47103J1051
Janux Therapeutics Inc
JANX
LISTED
NASDAQ
Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
News Preview
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms, today reported fi...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US56600D1072
Maravai LifeSciences Holdings Inc
MRVI
LISTED
NASDAQ
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
News Preview
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, together with other business updates.
Quarterly Results:
Revenue of $41.6 million, Net loss of $(45.1) milli...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US24661P8077
Delcath Systems, Inc.
DCTH
LISTED
NASDAQ
Delcath Systems to Participate in Upcoming Investor Conferences
News Preview
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following investor conferences:
Craig-Hallum Alpha Select Conference on Tuesday, November 18, 2025, in New York, NY
Canaccord Genuity MedTech, Di...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes to Participate in Two Upcoming Investor Conferences
News Preview
DUBLIN, Nov. 6, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences.
Stifel 2025 Healthcare Conference
Date/Time: Thursday, Nov. 13, 2025 at 2:40 p.m. ET (7:40 p.m. GMT)...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes to Participate in Two Upcoming Investor Conferences
News Preview
DUBLIN, Nov. 6, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences.
Stifel 2025 Healthcare Conference
Date/Time: Thursday, Nov. 13, 2025 at 2:40 p.m. ET (7:40 p.m. GMT)...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
News Preview
The Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards....
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US77313F1066
Rocket Pharmaceuticals Inc
RCKT
LISTED
NASDAQ
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
News Preview
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and recent operational results for the third quarter ending September 30, 2025.
“During the third quarter, we maintained disciplin...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
06.11.2025
ISIN: US09077V1008
BIOAGE Labs Inc
BIOA
LISTED
NASDAQ
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
News Preview
First participant dosed in Phase 1 trial of BGE-102, oral CNS-penetrant NLRP3 inhibitor, with initial SAD data expected by year-end...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US83601L1026
Sotera Health Co
SHC
LISTED
NASDAQ
Sotera Health Announces Secondary Offering of Common Stock
News Preview
Announcement of launch of secondary stock offering...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US7530181004
Rani Therapeutics Holdings, Inc.
RANI
LISTED
NASDAQ
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update
News Preview
– Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US5560991094
MacroGenics Inc
MGNX
LISTED
NASDAQ
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
News Preview
ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US8693671021
Sutro Biopharma Inc
STRO
LISTED
NASDAQ
Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights
News Preview
– Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004, its potential best-in-class Tissue Factor ADC; Expects to dose first patient before year-end –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US82024L1035
Shattuck Labs Inc
STTK
LISTED
NASDAQ
Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights
News Preview
–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US87918A1051
Teladoc Health Inc
TDOC
LISTED
NYSE
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
News Preview
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US29664W1053
Esperion Therapeutics Inc
ESPR
LISTED
NASDAQ
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
ANN ARBOR, Mich., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on November 4, 2025, the Company granted 23 new employees 77,650 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US1920051067
Codexis Inc
CDXS
LISTED
NASDAQ
Codexis Reports Third Quarter 2025 Financial Results
News Preview
Announces signing of $37.8m Supply Assurance Agreement with Merck...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US3795772082
Globus Medical Inc
GMED
LISTED
NYSE
Globus Medical Reports Third Quarter 2025 Results
News Preview
AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US0017441017
AMN Healthcare Services Inc
AMN
LISTED
NYSE
AMN Healthcare Announces Third Quarter 2025 Results
News Preview
Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US15687V1098
Certara Inc
CERT
LISTED
NASDAQ
Certara Reports Third Quarter 2025 Financial Results
News Preview
Updates Full Year 2025 Financial Guidance Updates Full Year 2025 Financial Guidance...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US23284F1057
CytomX Therapeutics Inc
CTMX
LISTED
NASDAQ
CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
News Preview
- CX-2051 Phase 1 data update on track for Q1 2026 -...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
News Preview
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company or Cidara), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today reported financial results for the third quarter ended September 30, 2025, and provided recent business updates....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US81578P1066
Seer Inc
SEER
LISTED
NASDAQ
Seer Reports Third Quarter 2025 Financial Results
News Preview
REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US7291391057
Pliant Therapeutics Inc
PLRX
LISTED
NASDAQ
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
News Preview
Oncology program advancing with data expected in the fourth quarter 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US14147L1089
Cardiff Oncology Inc
CRDF
LISTED
NASDAQ
Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update
News Preview
– Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US0144421072
Alector Inc
ALEC
LISTED
NASDAQ
Alector Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Selected lead candidates AL137 for the company’s Alector Brain Carrier (ABC)-enabled anti-amyloid beta antibody in Alzheimer's disease, and AL050 for its ABC-enabled GCase enzyme replacement therapy in Parkinson’s disease; both advancing toward IND-enabling studies...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek Biosciences to Participate in Upcoming Investor Conferences
News Preview
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences....
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Meridian Health Plan of Illinois and Centene Foundation Give $300,000 to Food Pantries to Help Tackle Food Insecurity in Illinois
News Preview
Donations strengthen community food resources for families struggling to access healthy food
CHICAGO, Nov. 6, 2025 /PRNewswire/ -- Meridian Health Plan of Illinois, Inc. (Meridian) and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC),...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
News Preview
Medicare beneficiaries with obesity or overweight will have access to
Zepbound and orforglipron, if approved, at $50 a month
INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement with the...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Superior HealthPlan and Centene Foundation Make $400,000 Investment to Help Tackle Food Insecurity in Texas
News Preview
Investment strengthens community food resources for families struggling to access healthy meals
AUSTIN, Texas, Nov. 6, 2025 /PRNewswire/ -- Superior HealthPlan and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), today announced a st...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US19249H1032
Coherus Oncology Inc
CHRS
LISTED
NASDAQ
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
News Preview
– Responsible for Corporate Development, Investor Relations, Government Affairs –...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Avantor, Inc. (AVTR) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Peri...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Baxter International
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of...
Themefolio
Profiler
Peergroup
© Newsfile
06.11.2025
ISIN: CA50206C1005
LIR Life Sciences Corp.
SKNY
LISTED
CSE
CSE Bulletin: Fundamental Change - Blackbird Critical Metals Corp./LIR Life Sciences Corp.
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 6 novembre/November 2025) - The common shares of LIR Life Sciences Corp. (SKNY), previously listed as Blackbird Critical Metals Corp. (BBRD), have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. LIR Life...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
News Preview
Novo Nordisk has agreed with the U.S. Administration to lower drug prices beginning in 2026 and expand patient access and affordability for semaglutide ......
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Nov. 6, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Deadline Soon: Savara Inc. (SVRA) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 7, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) securities between March 7, 2024 and May 23, 2025, inclusive (the “Class Period...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Molina Healthcare
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of do...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
News Preview
The Supervisory Board of Bayer AG has appointed Dr. Judith Hartmann to the company’s Board of Management, effective March 1, 2026. She will succeed Wolfgang Nickl as the company’s Chief Financial Officer (CFO) on June 1, 2026, following his planned retirement at the end of May 2026. Dr. Hartmann is currently an Operating Partner at Sandbrook Capit...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Avantor
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars fo...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Reuters Research Inc. (“MoonLake” or the “Company”) (NASDAQ: MLTX).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Cytokinetics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of mi...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: IS0000000040
Embla Medical hf
EMBLA
LISTED
CPH
Embla Medical Expands Support for Ukrainian Amputees with New Kyiv Clinic and Iceland Partnership
News Preview
REYKJAVIK, Iceland and COPENHAGEN, Denmark, Nov. 6, 2025 /PRNewswire/ -- Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced the official opening of its new prosthetic clinic in Kyiv.
At the clinic's opening ceremony, Embla Medical...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution
News Preview
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Lantheus
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Jasper Therapeutics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Savara
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at aTyr Pharma
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc.. (“Tvardi” or the “Company”) (NASDAQ: TVRD).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
California Seniors Now Have More Medicare Advantage and Medicare Prescription Drug Plans to Choose from in 2026 Thanks to Health Net and Centene
News Preview
Health Net to offer health plans for seniors in 13 select California counties
Nationally, Centene's Wellcare health plan will be available to more than 51 million beneficiaries in 32 states across more than 1,850 counties, including 13 in California...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics Announces Late-Breaking Data from Phase 3 DUPLEX Study of FILSPARI in FSGS Presented at the American Society of Nephrology (ASN) Kidney Week 2025
News Preview
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced new data from the Phase 3 DUPLEX Study demonstrating that patients with focal segmental glomerulosclerosis (FSGS) treated with FILSPARI® (sparsentan) were significantly more likely to reach proteinuria levels below 0.7 g/g compared to those receiving the maximum labeled dose of irbesartan,...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.11.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Reports Third Quarter 2025 Results
News Preview
Site Readiness Continues for Specialized Treatment Centers Envisioned to Support a Growing Number of Cell and Gene Therapy Trial Patients and Later Commercialization SOLANA BEACH, CA / ACCESS Newswire / November 6, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offerin...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.11.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Announces Agreement to Acquire IRRAS
News Preview
Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment of Intracranial Bleeding SOLANA BEACH, CALIFORNIA / ACCESS Newswire / November 6, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results
News Preview
Press Release – No. 15 / 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0060055861
Chemometec A/S
CHEMM
LISTED
CPH
Growth in revenue and operating profit
News Preview
Trading statement for Q1 2025/26 (1 July - 30 September 2025)...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
